Roswell Park Cancer Institute is a clinical research site located in Buffalo, New York, United States 14263.
Crixeo Health Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Roswell Park Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Carcinoma, Non-Small-Cell Lung.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Roswell Park Cancer Institute has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Roswell Park Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung.
Roswell Park Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.